Researchers in Korea have developed a new system to classify ANCA-associated vasculitis (AAV) into clusters, and provided an algorithm…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Subclinical changes are evident in the small blood vessels in the back of the eye and in the nails of…
The prognostic immune nutritional index or PINI — a novel clinical tool based on counts of immune cells and levels…
People with ANCA-associated vasculitis (AAV) who develop low antibody levels associated with rituximab treatment are at high risk…
A combination of two standardized scores of kidney damage can accurately predict the prognosis of renal disease in people with…
A new statistical model that considers age, disease type, patterns of organ involvement, and lab findings may help predict long-term…
Different types of disease-driving antibodies tend to associate with different symptoms of eosinophilic granulomatosis with polyangiitis (EGPA), the rarest form…
Women carrying a genetic mutation dubbed rs9274619 have a significantly higher risk of ANCA-associated vasculitis (AAV) associated with antibodies…
Physicians in the U.S. are excited about the potential of Tavneos (avacopan), an approved treatment for people with…
Many people with ANCA-associated vasculitis (AAV) have profound fatigue that’s severe enough to fulfill the diagnostic criteria for…